Guardian Pharmacy holder sells 3.57M GRDN shares

Bindley Capital Partners I, LLC, a 10% owner of Guardian Pharmacy Services, Inc., reported selling 3,570,677 shares of Class A common stock at an average price of $29.6825 per share on March 20, 2026.

Rhea-AI Filing Summary

Bindley Capital Partners I, LLC, a 10% owner of Guardian Pharmacy Services, Inc., reported selling 3,570,677 shares of Class A common stock at an average price of $29.6825 per share on March 20, 2026. The sale was made as part of an underwritten offering pursuant to an underwriting agreement with BofA Securities and Jefferies. After this transaction, Bindley Capital Partners I, LLC continues to hold 4,469,316 shares of Guardian Pharmacy Services Class A common stock.

Insights

Equity ownership and capital markets analyst

Large shareholder trims position via underwritten offering but remains a major holder.

Bindley Capital Partners I, LLC, identified as a 10% owner, sold 3,570,677 Guardian Pharmacy Services Class A shares at $29.6825. The footnote shows this occurred through an underwriting agreement with BofA Securities and Jefferies, indicating a structured secondary offering rather than routine open-market dribble selling.

The filing also shows Bindley Capital Partners I, LLC holding 4,469,316 shares after the sale, so it remains a significant shareholder. The net effect is a substantial reduction in its stake while still retaining a large position. The economic impact for other investors will depend on how the market absorbs the underwritten share supply.

Insider Trade Summary

Net Seller: 3,570,677 shares

Net Sell 1 txn

Insider Bindley Capital Partners I, LLC

Role 10% Owner

Sold 3,570,677 shs ($105.99M)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	3,570,677	$29.6825	$105.99M

Holdings After Transaction: Class A Common Stock — 4,469,316 shares (Direct)

Footnotes (1)

1. F1. Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders party thereto and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters named therein.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Bindley Capital Partners report for Guardian Pharmacy Services (GRDN)?

Bindley Capital Partners I, LLC reported selling 3,570,677 shares of Guardian Pharmacy Services Class A common stock. The shares were sold at an average price of $29.6825 each on March 20, 2026, as part of an underwritten offering arranged with major investment banks.

At what price were Guardian Pharmacy Services (GRDN) shares sold in the Form 4 filing?

The reported sale price was $29.6825 per share for Guardian Pharmacy Services Class A common stock. This price applies to the 3,570,677 shares sold by Bindley Capital Partners I, LLC in a single transaction executed on March 20, 2026 under an underwriting agreement.

How many Guardian Pharmacy Services (GRDN) shares does Bindley Capital Partners hold after the reported sale?

After the transaction, Bindley Capital Partners I, LLC holds 4,469,316 shares of Guardian Pharmacy Services Class A common stock. This figure reflects its remaining direct ownership following the sale of 3,570,677 shares disclosed in the Form 4 filing for March 20, 2026.

Was the Guardian Pharmacy Services (GRDN) insider sale part of an underwritten offering?

Yes. The footnote explains that the 3,570,677 Guardian Pharmacy Services shares were sold under an underwriting agreement dated March 18, 2026. BofA Securities and Jefferies acted as representatives of the several underwriters participating in this structured secondary share sale.

Who is the reporting person in the Guardian Pharmacy Services (GRDN) Form 4 filing?

The reporting person is Bindley Capital Partners I, LLC, listed as a 10% owner of Guardian Pharmacy Services, Inc. The Form 4 attributes the sale of 3,570,677 Class A common shares and the remaining 4,469,316 shares directly to this entity rather than to an individual executive.

Does Bindley Capital Partners remain a major shareholder of Guardian Pharmacy Services (GRDN) after the sale?

Yes. Despite selling 3,570,677 shares, Bindley Capital Partners I, LLC still holds 4,469,316 Guardian Pharmacy Services Class A shares. It continues to be reported as a 10% owner, indicating an ongoing, sizable equity position following the underwritten secondary sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/24/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bindley Capital Partners I, LLC

(Last) (First) (Middle)

8909 PURDUE ROAD, SUITE 500

(Street)

INDIANAPOLIS INDIANA 46268

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardian Pharmacy Services, Inc. [ GRDN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/20/2026		S(1)		3,570,677	D	$29.6825	4,469,316	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of Class A common stock, par value $0.001 per share, of Guardian Pharmacy Services, Inc. (the "Issuer"), sold pursuant to the Underwriting Agreement, dated March 18, 2026, by and among the Issuer, the selling stockholders party thereto and BofA Securities, Inc. and Jefferies LLC, as representatives of the several underwriters named therein.

	/s/ Douglas Towns, Attorney-in-Fact	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)